Medicis Pharmaceutical Corp. (MRX) Tops Q2 EPS by 6c; Issues Light Q3, FY12 Outlook

Go back to Medicis Pharmaceutical Corp. (MRX) Tops Q2 EPS by 6c; Issues Light Q3, FY12 Outlook
Medicis Pharmaceutical Corp. (NASDAQ: MRX) Delayed: 70.19 -1.69 (2.35%)
Previous Close $71.88    52 Week High $44.00 
Open $72.29    52 Week Low $30.30 
Day High $73.75    P/E 101.72 
Day Low $70.03    EPS $0.69 
Volume 426,813